CIK 0000879169
- Large accelerated filer
INCYTE CORP
Sign in to watch- Ticker
- INCY
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943136539
- Phone
- +1 302-498-6700
- Business address
- 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
- Former names
- INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,959,897
- in 5 filings, $33.0M under 10b5-1 plans
Net −$32,959,897. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-01 | Iyengar Vijay K EVP, GMAPPS | Grant or award | +10,982 | 52,799 | ||
| 2025-04-01 | Morrissey Michael James EVP, Head of Tech. Operations | Grant or award | +4,649 | 86,164 | ||
| 2025-04-01 | Stamoulis Christiana EVP & Chief Financial Officer | Grant or award | +18,598 | 110,123 | ||
| 2025-04-01 | Stamoulis Christiana EVP & Chief Financial Officer | Grant or award | +18,970 | 129,093 | ||
| 2025-04-01 | Stein Steven H EVP & Chief Medical Officer | Grant or award | +37,198 | 104,165 | ||
| 2025-04-01 | Stein Steven H EVP & Chief Medical Officer | Grant or award | +20,967 | 125,132 | ||
| 2025-04-01 | SWAIN PAULA J EVP, Human Resources | Grant or award | +11,159 | 96,362 | ||
| 2025-04-01 | SWAIN PAULA J EVP, Human Resources | Grant or award | +10,982 | 107,344 | ||
| 2025-04-01 | Hoppenot Herve Chairman / CEO | Grant or award | +66,899 | 563,573 | ||
| 2025-03-31 | Clancy Paul J Director | Grant or award 10b5-1 | +358 | $60.55 | $22K | 20,071 |
| 2025-03-31 | HARRIGAN EDMUND Director | Grant or award 10b5-1 | +363 | $60.55 | $22K | 17,434 |
| 2025-03-31 | BAKER BROS. ADVISORS LP Director | Grant or award | +487 | 2,813,892 | ||
| 2025-03-31 | BAKER BROS. ADVISORS LP Director | Grant or award | +487 | 28,184,571 | ||
| 2025-03-25 | Trotta Matteo EVP, GM, Dermatology US | Shares withheld for taxes | −537 | $62.08 | $33K | 9,937 |
| 2025-03-14 | Flannelly Barry P EVP & General Manager US | Sale 10b5-1 | −461 | $67.85 | $31K | 52,913 |
| 2025-03-14 | Flannelly Barry P EVP & General Manager US | Sale 10b5-1 | −199 | $67.88 | $14K | 52,714 |
| 2025-03-14 | Flannelly Barry P EVP & General Manager US | Sale 10b5-1 | −19,147 | $67.68 | $1.3M | 33,567 |
| 2025-03-04 | Denton Sheila A. EVP & General Counsel | Option exercise 10b5-1 | +599 | $58.06 | $35K | 26,447 |
| 2025-03-04 | Denton Sheila A. EVP & General Counsel | Sale 10b5-1 | −599 | $69.99 | $42K | 25,848 |
| 2025-03-04 | Denton Sheila A. EVP & General Counsel | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −599 | 18,552 |
Page 22 of 25 · 500 trades